CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

UBS Adjusts Eli Lilly Price Target to $1,425 From $1,250, Maintains Buy Rating

Positive
AI Analysis

Summary

UBS increased its price target on Eli Lilly to $1,425 from $1,250 while maintaining a Buy rating.

Importance:2/10
Sentiment:
0.30
analyst_ratingprice_targetequity_research
Related Companies

Read the original article

Published by yahoo_finance on July 13, 2026 1:54 PM

Read Original